AtaiBeckley (ATAI) Gains from Investment Securities (2020 - 2025)
AtaiBeckley (ATAI) reported Gains from Investment Securities of $3.8 million for Q2 2025, up 82.84% sequentially from $2.1 million in Q4 2024.
AtaiBeckley (ATAI) Gains from Investment Securities (2020 - 2025) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of Gains from Investment Securities data on file, last reported at $3.8 million in Q2 2025.
- For the quarter ending Q2 2025, Gains from Investment Securities changed N/A year-over-year to $3.8 million; the trailing twelve-month figure through Sep 2025 stood at $5.9 million (up 245.03% YoY), and the FY2024 full-year result was $2.1 million, changed N/A from the prior year.
- Gains from Investment Securities improved to $3.8 million in Q2 2025, from $2.1 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $16.5 million in Q4 2022 to a low of -$469000.0 in Q3 2021.
- A 5-year average of $2.3 million and a median of $972000.0 in 2021 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities tumbled 645.35% in 2021 and jumped 4641.48% in 2022, its largest moves.
- Tracing ATAI's Gains from Investment Securities over 5 years: stood at -$364000.0 in 2021, then jumped by 4641.48% to $16.5 million in 2022, then sank by 99.65% to $58000.0 in 2023, then soared by 3477.59% to $2.1 million in 2024, then soared by 82.84% to $3.8 million in 2025.
- Business Quant data shows ATAI's Gains from Investment Securities at $3.8 million in Q2 2025, $2.1 million in Q4 2024, and $1.7 million in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | AtaiBeckley | 1.56 Bn | 1.56 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3.79 Mn |
| Jun 30, 2025 | 3.79 Mn |
| Dec 31, 2024 | 2.08 Mn |
| Dec 31, 2024 | 2.08 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Sep 30, 2023 | 58,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Jun 30, 2023 | -76,000.00 |
| Jun 30, 2023 | -76,000.00 |
| Mar 31, 2023 | 1.03 Mn |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | 16.53 Mn |
| Dec 31, 2022 | 16.53 Mn |
| Sep 30, 2022 | -430,000.00 |
| Sep 30, 2022 | -430,000.00 |
| Jun 30, 2022 | -95,000.00 |
| Jun 30, 2022 | -95,000.00 |
| Mar 31, 2022 | 5.60 Mn |
| Mar 31, 2022 | 5.60 Mn |